Compstatin control peptide acetate

CAS No. 301544-78-5

Compstatin control peptide acetate( —— )

Catalog No. M37918 CAS No. 301544-78-5

Compstatin control peptide acetate is an inhibitor of complement protein C3 by binding and inhibiting the cleavage of complement C3.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 287 Get Quote
5MG 432 Get Quote
10MG 629 Get Quote
25MG 908 Get Quote
50MG 1260 Get Quote
100MG 1665 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Compstatin control peptide acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    Compstatin control peptide acetate is an inhibitor of complement protein C3 by binding and inhibiting the cleavage of complement C3.
  • Description
    Compstatin control peptide is a negative control of Compstatin (HY-P1036). Compstatin is a potent complement system C3 inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Complement System
  • Recptor
    Complement System
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    301544-78-5
  • Formula Weight
    1488.65
  • Molecular Formula
    C66H101N23O17
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 25 mg/mL (16.79 mM; Ultrasonic)
  • SMILES
    CC[C@H](C)[C@@H](C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](Cc1c[nH]c2c1cccc2)C(NCC(N[C@@H](Cc1c[nH]cn1)C(N[C@@H](Cc1c[nH]cn1)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@@H]([C@@H](C)O)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sahu A, et al. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J Immunol. 2000 Sep 1;165(5):2491-9.?
molnova catalog
related products
  • Tesidolumab

    Tesidolumab (LFG316) is a fully human IgG1/λ anti-C5 monoclonal antibody.

  • Complement factor D-...

    Complement factor D-IN-2 is an inhibitor of Complement factor D and reduces the excessive activation of complement factor D.

  • PMX53

    PMX53 (Ac-Phe-cyclo(Orn-Pro-D-Cha-Trp-Arg)) is a potent C5a receptor (CD88) antagonist with IC50 of 20 nM.